Prostate Undifferentiated Carcinoma
NCI Definition: An invasive prostate carcinoma characterized by the presence of undifferentiated malignant cells. 
There are 2 clinical trials for prostate undifferentiated carcinoma, of which 1 is open and 1 is completed or closed. Of the trials that contain prostate undifferentiated carcinoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 1/phase 2 (0 open).
Trx518, abiraterone, and avelumab are the most common interventions in prostate undifferentiated carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.